Cargando…
Ki-67 as a prognostic marker in mantle cell lymphoma—consensus guidelines of the pathology panel of the European MCL Network
Mantle cell lymphoma (MCL) has a heterogeneous clinical course and is mainly an aggressive B cell non-Hodgkin lymphoma; however, there are some indolent cases The Ki-67 index, defined by the percentage of Ki-67-positive lymphoma cells on histopathological slides, has been shown to be a very powerful...
Autores principales: | Klapper, Wolfram, Hoster, Eva, Determann, Olaf, Oschlies, Ilske, van der Laak, Jeroen, Berger, Françoise, Bernd, Heinz Wolfram, Cabeçadas, José, Campo, Elias, Cogliatti, Sergio, Hansmann, Martin Leo, Kluin, Philip M., Kodet, Roman, Krivolapov, Yuri A., Loddenkemper, Christoph, Stein, Harald, Möller, Peter, Barth, Thomas E. F., Müller-Hermelink, Konrad, Rosenwald, Andreas, Ott, German, Pileri, Stefano, Ralfkiaer, Elisabeth, Rymkiewicz, Grzegorz, van Krieken, Johan H., Wacker, Hans Heinrich, Unterhalt, Michael, Hiddemann, Wolfgang, Dreyling, Martin |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Springer-Verlag
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2725281/ https://www.ncbi.nlm.nih.gov/pubmed/19669190 http://dx.doi.org/10.1007/s12308-009-0036-x |
Ejemplares similares
-
Clinical outcome of Mantle Cell Lymphoma patients with high-risk disease (high-risk MIPI-c or high p53 expression)
por: Scheubeck, Gabriel, et al.
Publicado: (2023) -
Detection of EBV in reactive and neoplastic lymphoproliferations in adults—when and how?
por: Stuhlmann-Laeisz, Christiane, et al.
Publicado: (2014) -
The addition of rituximab to chemotherapy improves overall survival in mantle cell lymphoma—a pooled trials analysis
por: Fischer, Luca, et al.
Publicado: (2023) -
Rituximab Maintenance Versus Observation After Immunochemotherapy (R-CHOP, R-MCP, and R-FCM) in Untreated Follicular Lymphoma Patients: A Randomized Trial of the Ostdeutsche Studiengruppe Hämatologie und Onkologie and the German Low-Grade Lymphoma Study Group
por: Hirt, Carsten, et al.
Publicado: (2021) -
Quantification of minimal disseminated disease by quantitative polymerase chain reaction and digital polymerase chain reaction for NPM-ALK as a prognostic factor in children with anaplastic large cell lymphoma
por: Damm-Welk, Christine, et al.
Publicado: (2020)